NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









InduPro

InduPro

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.induprotx.com/

Last Round

Series B

Aug 12, 2026

Total Funding Raised

$162M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

InduPro is a biotechnology company that develops innovative therapeutics by manipulating protein pairings to create new signaling pathways and logic gates at the cell surface.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

oncology therapeuticsdrug discoveryprotein-based medicinebiotechbispecific antibodiesmultispecific antibodiesantibody drug conjugatesADCmembrane interactomicsMIntcell surface receptorsdrug development platformbiopharmaAI drug discoverycancer research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InduPro Comparables

Compare InduPro with similar companies based on industry and business-model similarity.

InduPro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Johnson & Johnson
80%
Stipple Bio
80%
Cartography Biosciences
80%

InduPro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 12, 2026
Corporate FundingJan 7, 2026
Corporate FundingDec 10, 2025
Series AJun 13, 2024

Key People

Founding team and executive leadership

Prakash Raman

Chief Executive Officer

Executive Team

InduPro Investors

Notable investors and investment history

InduPro investors
InvestorRounds
The Column GroupSeries B, Series A
Vida VenturesSeries B, Series A
The Chernin GroupSeries A
Solasta VenturesSeries B
Emerson CollectiveSeries B, Series A
Euclidean CapitalSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 12, 2026

    $77M round led by The Column Group.

  • Jan 7, 2026

    Eli Lilly and Company participated in the round.

InduPro Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

InduPro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InduPro's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range60
Year Founded2022
Last FundingAug 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.